Duality Biotherapeutics (HKG:9606) made a stellar trading debut in Hong Kong on Tuesday morning as its shares soared over 91% at the opening bell, defying the stock market volatility caused by the tariff war between the world's two largest economies.
The Chinese biotech firm opened at HK$181 per share, well above its initial public offering price of HK$94.60. As of 10:41 a.m., Hong Kong time, the stock traded at HK$209.60.
The company's debut takes place against a backdrop of heightened uncertainty in global equity markets, driven by escalating US-China trade tensions.